|
Mexico overtook the US in percent of overweight/obese people, so no surprise the relatively poor country also leads deaths related to diabetes.
I have no particular expertise on the subject, but it's not just US pharma companies keeping prices high, but every aspect of how we practice medicine. So many barriers to entry that keep competition out. We lose sight of the fact that the more hurdles we make people jump over, the higher the price. Allowing access to medicine to be controlled by a single private organization (American Medical Association) that has more interest in establishing their authority than improving patient outcomes results in outrageous pricing and suboptimal outcomes.
The AMA is like the Democrat party; keep people sick so they depend on the system.
|